Transcatheter Tricuspid Valve Interventions: a Narrative Review of Current Evidence and Future Directions
摘要
The review aims to delineate the developing role of transcatheter tricuspid valve interventions (TTVIs) whilst considering the current state of the evidence, preprocedural workup, developments, and outcomes based on current literature.
Recent FindingsTTVIs have made significant improvements in reducing TR and improving functional status in patients, especially in high-risk surgical cohorts. Innovations in device technology, such as the EVOQUE and LuX valves, have widened the scope of this intervention, offering tailored solutions for a wide range of anatomical and clinical challenges. Comparative analyses have indicated higher procedural success rates and improved patient outcomes compared to traditional surgical interventions.
SummaryTTVIs are redefining the management of tricuspid valve dysfunction by offering an effective and less invasive alternative to surgery. Despite promising short-term outcomes, questions of long-term durability require further research. Further innovation as well as larger clinical trials, will ensure this technique becomes a cornerstone in tricuspid valve management.